<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-ijerph-17-00440">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Siebert</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Sroczynski</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rossol</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wasem</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ravens-Sieberer</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Kurth</surname>
    <given-names>B.M.</given-names>
   </name>
   <name>
    <surname>Manns</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>McHutchison</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>J.B.</given-names>
   </name>
  </person-group>
  <article-title>Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C</article-title>
  <source>Gut</source>
  <year>2003</year>
  <volume>52</volume>
  <fpage>425</fpage>
  <lpage>432</lpage>
  <pub-id pub-id-type="doi">10.1136/gut.52.3.425</pub-id>
  <pub-id pub-id-type="pmid">12584228</pub-id>
 </element-citation>
</ref>
